ZyVersa Therapeutics (ZVSA) Stock Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ZVSA Stock Alerts $5.60 -0.87 (-13.45%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ZyVersa Therapeutics Stock Price Performance5 Day Performance+2.75%1 Month Performance-21.98%3 Month Performance-4.06%6 Month Performance-78.49%Year-To-Date Performance-37.78%1 Year Performance-97.24% Receive ZVSA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover ZVSA Stock Chart for Thursday, May, 9, 2024 ZVSA Chart by TradingView ZyVersa Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$6.47$5.60-13.45%$6.58$5.50137,940 shs$4.26 million05/07/2024$6.39$6.47+1.25%$6.69$6.06211,426 shs$4.92 million05/06/2024$5.45$6.39+17.25%$6.55$5.65514,208 shs$4.86 million05/03/2024$5.74$5.45-5.05%$6.00$5.25374,652 shs$4.14 million05/02/2024$5.24$5.74+9.54%$6.08$5.15203,548 shs$3.97 million05/01/2024$5.29$5.24-0.95%$5.90$5.15187,813 shs$3.98 million Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$5.77$5.29-8.32%$5.59$5.09188,843 shs$4.02 million04/29/2024$4.99$5.77+15.63%$6.70$5.158.04 million shs$4.39 million04/26/2024$6.08$4.99-17.86%$6.20$4.44439,563 shs$37.82 million04/25/2024$6.10$6.08-0.41%$6.30$5.6039,656 shs$4.61 million04/24/2024$5.72$6.10+6.64%$6.20$5.7432,864 shs$4.62 million04/23/2024$5.75$5.72-0.49%$5.85$5.5015,457 shs$4.34 million04/22/2024$5.86$5.75-1.91%$6.04$5.5024,136 shs$4.36 million04/19/2024$6.26$5.86-6.39%$6.40$5.7128,422 shs$4.44 million04/18/2024$5.83$6.26+7.47%$6.42$5.8342,202 shs$4.75 million04/17/2024$5.78$5.83+0.85%$6.00$5.6021,176 shs$4.42 million04/16/2024$6.36$5.78-9.11%$6.30$5.7032,927 shs$4.38 million04/15/2024$7.10$6.36-10.49%$7.30$6.3046,109 shs$4.82 million04/12/2024$7.50$7.10-5.33%$7.60$7.0035,659 shs$5.38 million04/11/2024$7.50$7.50$8.05$7.2037,224 shs$5.69 million04/10/2024$7.18$7.50+4.49%$7.50$7.0320,367 shs$5.69 million04/09/2024$7.33$7.18-2.05%$7.36$7.159,057 shs$5.44 million04/08/2024$7.34$7.33-0.11%$7.66$7.2019,113 shs$5.56 million04/05/2024$7.40$7.34-0.92%$7.46$7.2029,511 shs$5.56 million04/04/2024$7.13$7.40+3.92%$7.86$7.20111,254 shs$5.61 million04/03/2024$7.29$7.13-2.26%$7.50$6.9312,803 shs$5.40 million04/02/2024$7.43$7.29-1.88%$7.47$6.8116,410 shs$5.53 million04/01/2024$7.50$7.43-0.93%$7.65$7.2018,879 shs$5.63 million03/29/2024$7.50$7.50$8.40$7.4087,173 shs$5.69 million03/28/2024$7.78$7.50-3.54%$8.40$7.4086,534 shs$5.69 million03/27/2024$7.49$7.78+3.79%$7.82$7.1640,369 shs$5.89 million03/26/2024$8.00$7.49-6.36%$8.00$7.0944,762 shs$5.68 million03/25/2024$8.16$8.00-1.96%$8.17$7.8032,577 shs$6.06 million03/22/2024$8.20$8.16-0.49%$8.30$7.9023,917 shs$6.19 million03/21/2024$8.42$8.20-2.66%$8.56$8.0037,939 shs$6.22 million03/20/2024$8.11$8.42+3.87%$8.71$7.9031,051 shs$6.39 million03/19/2024$8.49$8.11-4.49%$8.50$7.6064,287 shs$6.15 million03/18/2024$7.81$8.49+8.79%$10.20$8.00705,359 shs$6.44 million03/15/2024$7.99$7.81-2.30%$8.34$7.8142,065 shs$5.92 million03/14/2024$7.81$7.99+2.29%$8.20$7.9038,744 shs$6.06 millionRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide03/13/2024$7.89$7.81-1.03%$8.20$7.5036,723 shs$5.92 million03/12/2024$8.66$7.89-8.87%$8.90$7.8047,759 shs$5.98 million03/11/2024$9.49$8.66-8.80%$9.73$8.20105,299 shs$6.56 million03/08/2024$9.55$9.49-0.57%$10.60$9.2081,810 shs$1.18 million03/07/2024$7.69$9.55+24.18%$10.80$7.60344,904 shs$1.18 million03/06/2024$8.60$7.69-10.59%$8.84$7.5070,975 shs$953,000.0003/05/2024$9.60$8.60-10.37%$9.10$8.3092,791 shs$1.07 million03/04/2024$10.40$9.60-7.74%$10.30$9.02108,470 shs$1.19 million03/01/2024$11.00$10.40-5.45%$11.80$10.20134,504 shs$1.29 million02/29/2024$10.00$11.00+10.00%$12.00$9.62391,632 shs$1.36 million02/28/2024$10.90$10.00-8.26%$12.40$9.31542,618 shs$1.24 million02/27/2024$10.80$10.90+0.93%$13.40$10.401.19 million shs$1.35 million02/26/2024$8.01$10.80+34.83%$25.00$10.408.87 million shs$1.34 million02/23/2024$6.20$8.01+29.13%$8.38$5.80715,935 shs$993,000.0002/22/2024$6.10$6.20+1.69%$7.28$6.10178,163 shs$769,000.0002/21/2024$5.97$6.10+2.25%$8.40$5.73392,608 shs$756,000.0002/20/2024$5.90$5.97+1.14%$6.20$5.8026,102 shs$743,000.0002/19/2024$5.90$5.90$6.20$5.8018,490 shs$731,000.0002/16/2024$5.77$5.90+2.22%$6.20$5.8018,485 shs$731,000.0002/15/2024$5.79$5.77-0.31%$6.20$5.6513,379 shs$718,000.0002/14/2024$5.55$5.79+4.25%$5.95$5.6012,231 shs$717,000.0002/13/2024$5.72$5.55-2.99%$5.80$5.5510,019 shs$688,000.0002/12/2024$5.84$5.72-1.99%$5.94$5.6314,793 shs$709,000.0002/09/2024$5.83$5.84+0.07%$6.10$5.727,787 shs$724,000.0002/08/2024$6.00$5.83-2.78%$6.00$5.4045,091 shs$723,000.00 Related Companies: SEEL Stock Price Chart KZIA Stock Price Chart NEXI Stock Price Chart PTPI Stock Price Chart DRUG Stock Price Chart CPHI Stock Price Chart LIPO Stock Price Chart SNPX Stock Price Chart GNPX Stock Price Chart GTBP Stock Price Chart Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVSA) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.